Forbes July 19, 2024
Robert Hart

Topline

Competition in the race to crack the lucrative weight loss drug market is heating up as rivals like Roche, Eli Lilly, Novo Nordisk and Pfizer develop oral medications that help people shed weight without an injection, a boon in the fight against obesity but a milestone experts say faces obstacles and is unlikely to eliminate the need for shots entirely.

Key Facts

Will Oral Weight Loss Drugs Replace Injectable Medicines?

Data from clinical trials suggest oral drugs compare favorably to injected weight loss medicines and could potentially offer a similar degree of weight loss with a similar set of side effects. It’s possible companies developing them could opt for lower degrees of weight loss to mitigate side effects or...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article